Results 141 to 150 of about 110,851 (248)

Rapamycin Prevents Sulfate-Reducing Bacteria-Induced Effects on Snail and GSK-3 and Impaired Intestinal Barrier. [PDF]

Microorganisms
Singh SB, Braun CA, Carroll-Portillo A, Lin HC.   +3 more
europepmc   +1 more source

GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells. [PDF]

Oncogenesis
Zhang L, Atencia Taboada L, Baglamis S, de Kroon M, Elshout C, Ramesh P, Helderman RFCPA, Torang A, Cameron K, van Driel MS, Wouters VM, van Neerven SM, Medema JP.   +12 more
europepmc   +1 more source

Nordentatin Inhibits Neuroblastoma Cell Proliferation and Migration through Regulation of GSK-3 Pathway. [PDF]

Curr Issues Mol Biol, 2022
Boonyarat C, Boonput P, Tongloh N, Kaewamatawong R, Chaiwiwatrakul S, Yenjai C, Waiwut P.   +6 more
europepmc   +1 more source

Balancing Immunity: GSK-3's Divergent Roles in Dendritic Cell-Mediated T-Cell Priming and Memory Responses. [PDF]

Int J Mol Sci
Fu C, Ma T, Zhou L, Mi QS, Jiang A.
europepmc   +1 more source

GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. [PDF]

Int J Mol Sci, 2023
Huntington KE, Louie AD, Srinivasan PR, Schorl C, Lu S, Silverberg D, Newhouse D, Wu Z, Zhou L, Borden BA, Giles FJ, Dooner M, Carneiro BA, El-Deiry WS.   +13 more
europepmc   +1 more source

Docking and structure activity relationship studies of potent and selective thiazolidinethione GSK-3 inhibitors. [PDF]

Bioorg Med Chem Lett
Boesger H, Williams K, Abdullai SA, Hubble B, Noori MS, Orac C, Amesaki DK, Ghazanfari D, Fairchild EA, Fatunbi OO, Pritchard JA, Goetz DJ, Hines JV, Bergmeier SC.   +13 more
europepmc   +1 more source

The GSK-3 Inhibitor CT99021 Enhances the Acquisition of Spatial Learning and the Accuracy of Spatial Memory. [PDF]

Front Mol Neurosci, 2021
Lee Y, Bortolotto ZA, Bradley CA, Sanderson TM, Zhuo M, Kaang BK, Collingridge GL.   +6 more
europepmc   +1 more source

Neoadjuvant Atezolizumab and Chemotherapy for Non‐Squamous Non‐Small Cell Lung Cancer: Efficacy and Safety Results of an Open‐Label, Single‐Arm, Phase II Trial

International Journal of Cancer, EarlyView.
Surgery plus chemotherapy is a well‐established treatment protocol for resectable, locally advanced non‐small cell lung cancer (NSCLC). Nonetheless, survival gains remain limited, emphasizing the need for more effective treatments. Here, the authors evaluated a novel approach using a neoadjuvant immunotherapy‐chemotherapy regimen consisting of ...
Benedikt Niedermaier, Tilmann Bochtler, Florian Eichhorn, Raffaella Griffo, Laura V. Klotz, Michael Allgäuer, Albrecht Stenzinger, Helge Bischoff, Marc A. Schneider, Petros Christopoulos, Uwe Haberkorn, Claus Peter Heussel, Inka Zoernig, Felix J. F. Herth, Michael Thomas, Alexander Rölle, Hauke Winter, Axel Benner, Dirk Jaeger, Martin E. Eichhorn   +19 more
wiley   +1 more source

The kinase GSK-3 alters the RNA-binding protein landscape of lipid metabolism transcripts leading to altered expression in the C. elegans nervous system. [PDF]

Nucleic Acids Res
Mahapatra A, Mohankumar M, Hundley HA.
europepmc   +1 more source

Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration. [PDF]

Cells, 2021
Rippin I, Eldar-Finkelman H.
europepmc   +1 more source